Distinctive patterns of G protein coupling induced by the structurally similar 5-HT<sub>2A</sub> receptor ligands ketanserin and altanserin in human prefrontal cortex.
Abstract
Antipsychotic activity of certain 5-HT<sub>2A</sub> receptor (5-HT<sub>2A</sub>R) antagonists has been attributed to inverse agonism. 5-HT<sub>2A</sub>R hallucinogenic agonists exhibit biased agonism toward G<sub>i/o</sub> proteins. Ketanserin and altanserin are 2 structurally similar orthosteric drugs used as 5-HT<sub>2A</sub>R therapeutic and radiotracers tools. This study assessed the pharmacological properties of ketanserin and altanserin, previously described as neutral 5-HT<sub>2A</sub>R antagonists, using postmortem human prefrontal cortex. Receptor radioligand binding experiments and functional [<sup>35</sup>S]GTPγS (sulfur 35 labeled guanosine-5'-O-[gamma-thio]-triphosphate) binding assays followed by immunocapture with anti-Gα<sub>q/11</sub> and anti-Gα<sub>i1</sub> protein antibodies were performed. Molecular dynamics simulations were used to ascertain binding modes to the 5-HT<sub>2A</sub>R. [<sup>3</sup>H]Ketanserin binding to 5-HT<sub>2A</sub>Rs was decreased by guanylyl-5'-imido-diphosphate, a GTP analog. Guanylyl-5'-imido-diphosphate transformed the biphasic inhibition of [<sup>3</sup>H]ketanserin binding by the agonist (±)DOI into a monophasic low-affinity curve. Ketanserin stimulated [<sup>35</sup>S]GTPγS binding to Gα<sub>q/11</sub> but not Gα<sub>i1</sub> proteins. Conversely, altanserin inhibited [<sup>35</sup>S]GTPγS binding to Gα<sub>i1</sub> but not Gα<sub>q/11</sub> proteins. These effects were blocked by the neutral antagonist MDL-11,939. Altanserin-induced inhibition was abolished by the Gα<sub>i/o</sub> alkylating agent N-ethylmaleimide. Similar findings were observed in wild type but disappeared in 5-HT<sub>2A</sub>R knockout mice. Ketanserin and altanserin showed distinct interactions within residues S2.61, S5.46, and N6.55 in the 5-HT<sub>2A</sub>R binding pocket. Therefore, ketanserin and altanserin elicit biased signaling with different patterns of G protein modulation upon interacting with 5-HT<sub>2A</sub>Rs in brain. Ketanserin behaves as partial agonist on G<sub>q/11</sub>, whereas altanserin acts as inverse agonist on G<sub>i1</sub> proteins. These findings should influence the design of antipsychotic drugs targeting this receptor and when used as antagonists and radiotracers for the 5-HT<sub>2A</sub>R assessment. SIGNIFICANCE STATEMENT: Ketanserin and altanserin are categorized as neutral 5-HT<sub>2A</sub> receptor antagonists. This study shows differential patterns of 5-HT<sub>2A</sub> receptor coupling to Gα<sub>q/11</sub> and Gα<sub>i1</sub> proteins between ketanserin and altanserin and demonstrates biased signaling and inverse agonism in human brain.
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Keywords
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.